Argus analyst John Eade raised the price target on Novo Nordisk (NYSE: NVO) to $160.00 (from $125.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE